| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.1 | 0.5 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |